Literature DB >> 17704286

The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.

Hiroshi Sato1, Roberto Bolli, Gregg D Rokosh, Qiuli Bi, Shujing Dai, Gregg Shirk, Xian-Liang Tang.   

Abstract

The present study sought to determine whether the combination of late preconditioning (PC) with postconditioning enhances the reduction in infarct size. Chronically instrumented rats were assigned to a 45-min (subset 1) or 60-min (subset 2) coronary occlusion followed by 24 h of reperfusion. In each subset, rats received no further intervention (control) or were preconditioned 24 h before occlusion (PC), postconditioned at the onset of reperfusion following occlusion, or preconditioned and postconditioned without (PC + postconditioning) or with the COX-2 inhibitor celecoxib (3 mg/kg ip; PC + postconditioning + celecoxib) 10 min before postconditioning. Myocardial cyclooxygenase-2 (COX-2) protein expression and COX-2 activity (assessed as myocardial levels of PGE(2)) were measured 6 min after reperfusion in an additional five groups (control, PC, postconditioning, PC + postconditioning, and PC + postconditioning + celecoxib) subjected to a 45-min occlusion. PC alone reduced infarct size after a 45-min occlusion but not after a 60-min occlusion. Postconditioning alone did not reduce infarct size in either setting. However, the combination of late PC and postconditioning resulted in a robust infarct-sparing effect in both settings, suggesting additive cardioprotection. Celecoxib completely abrogated the infarct-sparing effect of the combined interventions in both settings. Late PC increased COX-2 protein expression and PGE(2) content. PGE(2) content (but not COX-2 protein) was further increased by the combination of both interventions, suggesting that postconditioning increases the activity of COX-2 induced by late PC. In conclusion, the combination of late PC and postconditioning produces additive protection, likely due to a postconditioning-induced enhancement of COX-2 activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704286      PMCID: PMC3713472          DOI: 10.1152/ajpheart.00858.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

1.  Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection?

Authors:  Karin Przyklenk; Gerd Heusch
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

2.  Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation.

Authors:  Xi-Ming Yang; Sebastian Philipp; James M Downey; Michael V Cohen
Journal:  Basic Res Cardiol       Date:  2004-11-25       Impact factor: 17.165

3.  Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min.

Authors:  Xian-Liang Tang; Hiroshi Sato; Sumit Tiwari; Buddhadeb Dawn; Qiuli Bi; Qianhong Li; Gregg Shirk; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-06-30       Impact factor: 4.733

4.  Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits.

Authors:  Ken Shinmura; Eitaro Kodani; Yu-Ting Xuan; Buddhadeb Dawn; Xian-Liang Tang; Roberto Bolli
Journal:  J Am Coll Cardiol       Date:  2003-04-02       Impact factor: 24.094

5.  The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning.

Authors:  R Bolli; S Manchikalapudi; X L Tang; H Takano; Y Qiu; Y Guo; Q Zhang; A K Jadoon
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

6.  Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.

Authors:  Amanda J Zatta; Hajime Kin; George Lee; Ningping Wang; Rong Jiang; Robert Lust; James G Reeves; James Mykytenko; Robert A Guyton; Zhi-Qing Zhao; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2006-01-27       Impact factor: 10.787

7.  Postconditioning inhibits mitochondrial permeability transition.

Authors:  Laurent Argaud; Odile Gateau-Roesch; Olivier Raisky; Joseph Loufouat; Dominique Robert; Michel Ovize
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

8.  Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

Authors:  Xi-Ming Yang; J Bradley Proctor; Lin Cui; Thomas Krieg; James M Downey; Michael V Cohen
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

9.  Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.

Authors:  Dunbar Alcindor; John G Krolikowski; Paul S Pagel; David C Warltier; Judy R Kersten
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

10.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.

Authors:  Buddhadeb Dawn; Yu-Ting Xuan; Yiru Guo; Arash Rezazadeh; Adam B Stein; Greg Hunt; Wen-Jian Wu; Wei Tan; Roberto Bolli
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

View more
  12 in total

1.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

2.  Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice.

Authors:  Bhavesh Sojitra; Yogesh Bulani; Uday Kumar Putcha; Abhinav Kanwal; Prachi Gupta; Madhusudana Kuncha; Sanjay Kumar Banerjee
Journal:  Mol Cell Biochem       Date:  2011-08-31       Impact factor: 3.396

3.  Hyperbaric oxygen for cerebral vasospasm and brain injury following subarachnoid hemorrhage.

Authors:  Robert P Ostrowski; John H Zhang
Journal:  Transl Stroke Res       Date:  2011-09-01       Impact factor: 6.829

4.  Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats.

Authors:  L-W Fan; A Kaizaki; L-T Tien; Y Pang; S Tanaka; S Numazawa; A J Bhatt; Z Cai
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

5.  Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Zo Rakotoniaina; Pascal Guerard; Frédéric Lirussi; Luc Rochette; Monique Dumas; Françoise Goirand; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-10       Impact factor: 3.000

6.  Correlation of modification of heart rate recovery with adaptation to myocardial ischemia in a model of sequential exercise testings.

Authors:  Andreas P Michaelides; Christos A Fourlas; George K Andrikopoulos; Charalambos Antoniades; Dimitrios Soulis; Evangelos Chatzistamatiou; Christodoulos I Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

7.  Galangin Resolves Cardiometabolic Disorders through Modulation of AdipoR1, COX-2, and NF-κB Expression in Rats Fed a High-Fat Diet.

Authors:  Patoomporn Prasatthong; Sariya Meephat; Siwayu Rattanakanokchai; Juthamas Khamseekaew; Sarawoot Bunbupha; Parichat Prachaney; Putcharawipa Maneesai; Poungrat Pakdeechote
Journal:  Antioxidants (Basel)       Date:  2021-05-12

8.  The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning.

Authors:  Yiru Guo; Deepali Nivas Tukaye; Wen-Jian Wu; Xiaoping Zhu; Michael Book; Wei Tan; Steven P Jones; Gregg Rokosh; Shuh Narumiya; Qianhong Li; Roberto Bolli
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.

Authors:  Asuka Kaizaki; Lu-Tai Tien; Yi Pang; Zhengwei Cai; Sachiko Tanaka; Satoshi Numazawa; Abhay J Bhatt; Lir-Wan Fan
Journal:  J Neuroinflammation       Date:  2013-04-05       Impact factor: 8.322

Review 10.  The paradigm of postconditioning to protect the heart.

Authors:  C Penna; D Mancardi; S Raimondo; S Geuna; P Pagliaro
Journal:  J Cell Mol Med       Date:  2007-12-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.